Bio Solution Co.,Ltd.

Develops cell therapies for degenerative diseases and supplies bio-lab reagents for R&D.

086820 | KO

Overview

Corporate Details

ISIN(s):: N/A
LEI:
Country:: South Korea
Address:: 서울특별시 노원구 공릉로 232 5층 (공릉동, 서울테크노파크), 서울특별시
Website:: https://bio-solution.co.kr/
Sector:: Manufacturing
Industry:: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Based on the provided sources, Bio Solution Co., Ltd. is a biotechnology and life sciences company, not a financial data provider. The company develops, manufactures, and sells cell therapy products for degenerative diseases. Its offerings include CartiLife, an autologous chondrocyte cell-based therapy. Additionally, the company produces and supplies a range of bio-laboratory reagents and kits for research and development purposes. These products are used in applications such as yeast two-hybrid assays, nucleic acid precipitation, and protein and DNA electrophoresis. The company is ISO 13485:2016 certified, indicating adherence to quality management standards for medical devices.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for Bio Solution Co.,Ltd. and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Bio Solution Co.,Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Bio Solution Co.,Ltd. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
AnGes, Inc. Develops gene-based medicines like HGF gene therapy, DNA vaccines, and NF-kB decoys.	Japan	4563
ANIMALCARE GROUP PLC Develops & sells veterinary prescription & OTC medicines for professionals worldwide.	United Kingdom	ANCR
Annexin Pharmaceuticals AB Developing Annexin A5 protein to treat vascular, inflammatory, and cancerous diseases.	Sweden	ANNX
ANTEROGEN CO., LTD. Develops and commercializes adult stem cell therapies and orphan drugs for medical conditions.	South Korea	065660
Antibiotice S.A. Develops and manufactures generic medicines and APIs, specializing in anti-infectives.	Romania	ATB
Apontis Pharma AG German pharma firm specializing in Single Pills for cardiovascular and chronic diseases.	Germany	APPH
AprilBio Co.,Ltd. Develops long-acting biologic drugs for autoimmune diseases and oncology using its SAFA™ platform.	South Korea	397030
Aprogen Biologics Inc. Develops and manufactures novel biologic drugs and biosimilars for the professional market.	South Korea	003060
Aprogen, Inc Develops and manufactures novel biologics and biosimilars for cancer and arthritis treatments.	South Korea	007460
Aptabio Therapeutics Inc. Develops drugs for fibrosis, inflammation, and cancer using NOX inhibitor & CAF modulation tech.	South Korea	293780